Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease

Clin Kidney J. 2019 Jun 17;13(1):72-74. doi: 10.1093/ckj/sfz076. eCollection 2020 Feb.

Lisa N van der Vorm^{1

2

3}, Ruben Visser⁴, Dana Huskens^{1

2}, Alicia Veninga², Denise L Adams⁴, Jasper A Remijn^{1

3

5}, Hendrik C Hemker^{1

2}, Pieter L Rensma⁴, Remco van Horssen⁶, Bas de Laat^{1

2

3}

¹ Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
² Synapse Research Institute, Maastricht, The Netherlands.
³ Department of Clinical Chemistry and Hematology, Gelre Hospitals, Apeldoorn, The Netherlands.
⁴ Department of Nephrology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
⁵ Department of Clinical Chemistry, Meander Medical Center, Amersfoort, The Netherlands.
⁶ Department of Clinical Chemistry and Hematology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

No abstract available